These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1374 related items for PubMed ID: 19785914
1. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T. Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914 [Abstract] [Full Text] [Related]
2. Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats. Rock EM, Limebeer CL, Petrie GN, Williams LA, Mechoulam R, Parker LA. Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834 [Abstract] [Full Text] [Related]
3. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats. Taffe MA, Creehan KM, Vandewater SA. Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111 [Abstract] [Full Text] [Related]
4. Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway. Todd SM, Zhou C, Clarke DJ, Chohan TW, Bahceci D, Arnold JC. Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732 [Abstract] [Full Text] [Related]
5. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. Invest Ophthalmol Vis Sci; 2018 Dec 03; 59(15):5904-5911. PubMed ID: 30550613 [Abstract] [Full Text] [Related]
6. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations. Moore CF, Weerts EM. Psychopharmacology (Berl); 2022 May 03; 239(5):1397-1408. PubMed ID: 34652500 [Abstract] [Full Text] [Related]
7. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. J Pharmacol Exp Ther; 2005 Jul 03; 314(1):329-37. PubMed ID: 15831444 [Abstract] [Full Text] [Related]
8. Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556. Colodete DAE, Silva NR, Pedrazzi JFC, Fogaça MV, Cortez I, Del-Bel EA, Breuer A, Mechoulam R, Gomes FV, Guimarães FS. Behav Pharmacol; 2023 Jun 01; 34(4):213-224. PubMed ID: 37171460 [Abstract] [Full Text] [Related]
9. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice. Gomes FV, Issy AC, Ferreira FR, Viveros MP, Del Bel EA, Guimarães FS. Int J Neuropsychopharmacol; 2014 Oct 31; 18(5):. PubMed ID: 25618402 [Abstract] [Full Text] [Related]
10. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T, Gunasekaran N, Karl T, Long LE, Huang XF, Liu K, Arnold JC, McGregor IS. Psychopharmacology (Berl); 2011 Nov 31; 218(2):443-57. PubMed ID: 21667074 [Abstract] [Full Text] [Related]
11. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC. Hložek T, Uttl L, Kadeřábek L, Balíková M, Lhotková E, Horsley RR, Nováková P, Šíchová K, Štefková K, Tylš F, Kuchař M, Páleníček T. Eur Neuropsychopharmacol; 2017 Dec 31; 27(12):1223-1237. PubMed ID: 29129557 [Abstract] [Full Text] [Related]
12. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Parker LA, Burton P, Sorge RE, Yakiwchuk C, Mechoulam R. Psychopharmacology (Berl); 2004 Sep 31; 175(3):360-6. PubMed ID: 15138755 [Abstract] [Full Text] [Related]
13. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats. Malone DT, Jongejan D, Taylor DA. Pharmacol Biochem Behav; 2009 Aug 31; 93(2):91-6. PubMed ID: 19393686 [Abstract] [Full Text] [Related]
14. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O'Carrol C, Atakan Z, Zuardi AW, McGuire PK. Arch Gen Psychiatry; 2009 Jan 31; 66(1):95-105. PubMed ID: 19124693 [Abstract] [Full Text] [Related]
15. Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress. Fokos S, Panagis G. J Psychopharmacol; 2010 May 31; 24(5):767-77. PubMed ID: 19406854 [Abstract] [Full Text] [Related]
16. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats. Javadi-Paydar M, Nguyen JD, Kerr TM, Grant Y, Vandewater SA, Cole M, Taffe MA. Psychopharmacology (Berl); 2018 Sep 31; 235(9):2541-2557. PubMed ID: 29907926 [Abstract] [Full Text] [Related]
17. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Roser P, Juckel G, Rentzsch J, Nadulski T, Gallinat J, Stadelmann AM. Eur Neuropsychopharmacol; 2008 Aug 31; 18(8):569-77. PubMed ID: 18544469 [Abstract] [Full Text] [Related]
19. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study. Sainz-Cort A, Jimenez-Garrido D, Muñoz-Marron E, Viejo-Sobera R, Heeroma J, Bouso JC. J Clin Psychopharmacol; 2008 Aug 31; 41(5):561-570. PubMed ID: 34412109 [Abstract] [Full Text] [Related]
20. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? Salviato BZ, Raymundi AM, Rodrigues da Silva T, Salemme BW, Batista Sohn JM, Araújo FS, Guimarães FS, Bertoglio LJ, Stern CA. Neuropharmacology; 2021 Sep 15; 196():108684. PubMed ID: 34181978 [Abstract] [Full Text] [Related] Page: [Next] [New Search]